ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | | | | |
|
| | Tissue enhanced | 0 |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | | | | | |
| | Tissue enhanced | 0 |
ANXA13 | Annexin A13 | | | | |
|
| Plasma membrane | Tissue enhanced | 0 |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | | | | |
|
| | Tissue enhanced | 0 |
BDKRB1 | Bradykinin receptor B1 | | | | |
|
| | Tissue enhanced | 0 |
C4orf6 | Chromosome 4 open reading frame 6 | | | | | |
| | Tissue enhanced | 0 |
C6orf141 | Chromosome 6 open reading frame 141 | | | | |
|
| Nuclear membrane | Tissue enhanced | 0 |
CA9 | Carbonic anhydrase IX | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
CAPN12 | Calpain 12 | | | | |
|
| | Tissue enhanced | 0 |
CATSPERB | Catsper channel auxiliary subunit beta | | | | |
|
| | Tissue enhanced | 0 |
CCL20 | Chemokine (C-C motif) ligand 20 | | | | | |
| | Tissue enhanced | 0 |
CHRM2 | Cholinergic receptor, muscarinic 2 | | | | |
|
| | Tissue enhanced | 0 |
CILP2 | Cartilage intermediate layer protein 2 | | | | |
|
| | Tissue enhanced | 0 |
CLDN2 | Claudin 2 | | | | |
|
| Nucleus but not nucleoli Cell Junctions | Tissue enhanced | 0 |
COL10A1 | Collagen, type X, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
COL3A1 | Collagen, type III, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
COLEC11 | Collectin sub-family member 11 | | | | |
|
| Cytoplasm Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
COMP | Cartilage oligomeric matrix protein | | | | | |
| | Tissue enhanced | 0 |
CPA3 | Carboxypeptidase A3 (mast cell) | | | | |
|
| | Tissue enhanced | 0 |
CPXM1 | Carboxypeptidase X (M14 family), member 1 | | | | |
|
| | Tissue enhanced | 0 |
CRLF2 | Cytokine receptor-like factor 2 | | | | | |
| | Tissue enhanced | 0 |
CTHRC1 | Collagen triple helix repeat containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | | | | | |
| | Tissue enhanced | 0 |
DCDC1 | Doublecortin domain containing 1 | | | | |
|
| | Tissue enhanced | 0 |
DEPDC1B | DEP domain containing 1B | | | | |
|
| Golgi apparatus Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
DUOX2 | Dual oxidase 2 | | | | | |
| | Tissue enhanced | 0 |
DUOXA2 | Dual oxidase maturation factor 2 | | | | |
|
| | Tissue enhanced | 0 |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | | | | | |
| | Tissue enhanced | 0 |
FAM150A | Family with sequence similarity 150, member A | | | | |
|
| | Tissue enhanced | 0 |
FAM180A | Family with sequence similarity 180, member A | | | | |
|
| | Tissue enhanced | 0 |
FGF5 | Fibroblast growth factor 5 | | | | |
|
| Nucleus Nucleoli Cytoplasm | Tissue enhanced | 0 |
FGF7 | Fibroblast growth factor 7 | | | | |
|
| | Tissue enhanced | 0 |
FNDC1 | Fibronectin type III domain containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
FOSL1 | FOS-like antigen 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
FOXL1 | Forkhead box L1 | | | | | |
| | Tissue enhanced | 0 |
GEM | GTP binding protein overexpressed in skeletal muscle | | | | |
|
| | Tissue enhanced | 0 |
GLP2R | Glucagon-like peptide 2 receptor | | | | |
|
| | Tissue enhanced | 0 |
GPBAR1 | G protein-coupled bile acid receptor 1 | | | | |
|
| | Tissue enhanced | 0 |
GPX2 | Glutathione peroxidase 2 (gastrointestinal) | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
GREM1 | Gremlin 1, DAN family BMP antagonist | | | | |
|
| | Tissue enhanced | 0 |
GREM2 | Gremlin 2, DAN family BMP antagonist | | | | |
|
| | Tissue enhanced | 0 |
HMSD | Histocompatibility (minor) serpin domain containing | | | | | |
| | Tissue enhanced | 0 |
ITGBL1 | Integrin, beta-like 1 (with EGF-like repeat domains) | | | | |
|
| | Tissue enhanced | 0 |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | | | | | |
| | Tissue enhanced | 0 |
KERA | Keratocan | | | | |
|
| | Tissue enhanced | 0 |
KRT222 | Keratin 222 | | | | |
|
| | Tissue enhanced | 0 |
LCN2 | Lipocalin 2 | | | | |
|
| | Tissue enhanced | 0 |
LGALS2 | Lectin, galactoside-binding, soluble, 2 | | | | |
|
| | Tissue enhanced | 0 |
LHX8 | LIM homeobox 8 | | | | | |
| | Tissue enhanced | 0 |